Key Points
- Globe Life CFO Thomas Peter Kalmbach sold 21,000 shares at an average price of $180.06, generating $3.78 million. His remaining ownership fell 29.34% to 50,568 shares.
- Globe Life reported quarterly EPS of $3.61, slightly below the $3.67 consensus, while revenue rose 8% year over year to $1.60 billion. The company issued fiscal 2026 EPS guidance of $15.55–$15.95.
- Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $191.67 target price; shares recently opened at $182.65, near their 52-week high of $191.55.
Globe Life Inc. (NYSE:GL - Get Free Report) CFO Thomas Peter Kalmbach sold 21,000 shares of Globe Life stock in a transaction that occurred on Thursday, July 30th. The stock was sold at an average price of $180.06, for a total transaction of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares of the company's stock, valued at $9,105,274.08. This trade represents a 29.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Tuesday, July 28th, Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock. The shares were sold at an average price of $178.58, for a total transaction of $4,580,577.00.
- On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24.
- On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total transaction of $1,864,128.83.
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05.
Globe Life Price Performance
NYSE GL opened at $182.65 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The stock's fifty day moving average price is $171.01 and its 200 day moving average price is $154.07. Globe Life Inc. has a 1 year low of $127.85 and a 1 year high of $191.55. The company has a market cap of $14.18 billion, a price-to-earnings ratio of 12.13 and a beta of 0.47.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the firm posted $3.05 EPS. The business's revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current year.
Analyst Upgrades and Downgrades
GL has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their target price on Globe Life from $181.00 to $201.00 and gave the stock an "overweight" rating in a report on Tuesday, July 21st. Truist Financial increased their price target on shares of Globe Life from $180.00 to $185.00 and gave the stock a "buy" rating in a report on Friday, April 24th. Wells Fargo & Company raised their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an "overweight" rating in a research report on Thursday, July 9th. Weiss Ratings cut shares of Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, July 20th. Finally, TD Cowen lifted their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a "buy" rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $191.67.
View Our Latest Research Report on Globe Life
Hedge Funds Weigh In On Globe Life
A number of institutional investors have recently modified their holdings of the stock. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the second quarter worth about $28,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the second quarter worth about $31,000. Torren Management LLC purchased a new position in Globe Life during the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc raised its position in Globe Life by 41.1% during the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company's stock valued at $44,000 after acquiring an additional 92 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.
Globe Life Company Profile
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
